XStream Systems' XT250 material identification system made its debut at the UK Royal Pharmaceutical Society's Combating Counterfeiting conference held in London.
With the World Health Organization (WHO) estimating that up to 1% of medicines in the developed world and up to 10% globally are counterfeit, the threat to health has never been greater.
Cutting edge technologies are constantly being developed to combat this growth with most focusing on pedigree verification of the documentation trail through the supply chain or unique packaging processes. The XT250, however, is capable of scanning the pharmaceuticals inside the manufacturers packaging while leaving the seal intact.
XStream Systems claims success rates higher than 99% with the XT250 able to identify the authenticity of a drug within a matter of minutes, using patented Energy Dispersive X-Ray Diffraction (EDXRD).
Easy to use with a customisable touch screen, the XT250 provides a high-end laboratory function outside the laboratory that can deliver indisputable, reliable supply chain safety.
It is available in the UK through distributor Omicron Research, based in Marlborough, Wiltshire.
XStream Systems
T +44 1672 541425
info@omicron-uk.com